TABLE 2.
Country and area | Collection yr | Sample source (ref.) | No. of isolates | Wild-type sequences (n [%]) | NS-SNPsa (n [%]) | Resistant mutants (n) | NS-SNP |
---|---|---|---|---|---|---|---|
Solomon Islands | |||||||
Malaita | 2008 | Therapeutic efficacy study | 26 | 24 (92) | 2 (8) | 0 | V652L |
Vanuatu | |||||||
Tanna | 2008 | Community survey (58) | 11 | 11 (100) | 0 (0) | 0 | NA |
Epi Island | 2011 | Therapeutic efficacy study | 22 | 21 (95) | 1 (5) | 0 | I537V |
Total | 59 | 56 (95) | 3 (5) | 0 |
NS-SNP, nonsynonymous sequence polymorphisms.